Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti- nuclear autoantibodies in connective tissue disorders

Clinical and Experimental Rheumatology

Volumn 17, Issue 2, 1999, Pages 205-214

  Meheus, L ^a   Van Venrooij, W J ^b   Wiik, A ^c   Charles, P J ^d   Tzioufas, A G ^e   Meyer, O ^f   Steiner, G ^g   Gianola, D ^h   Bombardieri, S ^h   Union, A ^a   De Keyser, S ^a   Veys, E ⁱ   De Keyser, F ⁱ  

^a INNOGENETICS   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Statents Seruminstitut ^*  (Denmark)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY OF PISA   (Italy)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Autoantibodies; Recombinant autoantigens

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIGENS; CONNECTIVE TISSUE DISEASES; FEASIBILITY STUDIES; HUMANS; IMMUNOASSAY; IMMUNOBLOTTING; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0032966086     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. HUMBEL RL: Detection of antinuclear antibodies by immunofluorescence. In VAN VENROOIJ WJ and MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers 1993:A2:1-16.
2. VON MÜHLEN CA. TAN EM: Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24:323-58.
3. ST CLAIR EW: Recombinant autoantigens. In PETER JB and SHOENFELD Y (Eds.): Autoantibodies. Amsterdam, Elsevier Sciences 1996: 668-76.
4. VERHEIJEN R, DE JONG BAW, OBERYÉ EHH, VAN VENROOIJ WJ: Molecular cloning of a major CENP-B epitiope and its use for the detection of anticentromere autoantibodies. Mol Biol Reports 1992; 16: 49-59.
5. BRINGMANN P, RINKE J, APPEL B, REUTER R.LÜHRMANN R: Purification of snRNPs U1, U2, U4, U5 and U6 with 2,2,7-trimethyl-guanosine-specific antibody and definition of their constituent proteins reacting with anti-Sm and anti-(U1)RNP antisera. EMBO J 1983; 2: 1129-35.
6. LERMEIER T, FOULAKI K, LÜHRMANN R: Evidence for three distinct D proteins, which react differentially with anti-Sm autoantibodies, in the cores of the major snRNPs U1, U2, U4/U6 and U5. Nucleic Acids Res 1990; 18: 6475-84.
7. ELKON KB: Ribosomal RNP. In VAN VENROOIJ WJ and MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers 1994: B2: 5:1-11.
8. POLLET DE, SAMAN EL, PEETERS DC et al: Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides. Clin Chem 1991;37: 1700-7.
9. MAERTENS G, DEKEYSER F, VAN GEEL A et al: Combination of HCV antibodies by the Line Immunoassay INNO-LIA HCVAb III. In LAU J (Ed.): Methods in Molecular Medicine, Hepatitis C - Section 1, Chapter 4. Totowa (NJ), Human Press, 1998:11-26.
10. AVRAMEAS S, TERNYNCK T: Natural autoantibodies: The other side of the immune system. Res Immunol 1995; 146: 235-48.
11. SLOBBE RL, PLUK W, VAN VENROOIJ WJ, PRUIJN GJM: Ro ribonucleoprotein assembly in vitro, identification of RNA-protein and protein-protein interactions.J Mol Biol 1992; 277: 361-6.
12. BUYON JP, SLADE SG, CHAN EKL, TAN EM, WINCHESTER R: Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 1990; 129: 207-10.
13. COHEN MJ: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
14. ROKEACH LA, HASELBY JA, HOCH SO: Overproduction of human snRNP-associated SmD autoantigen in Escherichia coli and Saccharomyces cerevisiae. Gene 1992; 118:247-53.
15. WAGATSUMA M, ASAMI N, MIYACHI J, UCHIDA S, WATANABE H, AMANN E: Antibody recognition of the recombinant human nuclear antigen RNP 70kD, SS-A, SS-B, Sm-D by autoimmune sera. Mol Immunol 1993; 30: 1491-8.
16. BRAHMS H, RAKER VA, VAN VENROOU WJ, LÜHRMAN R: A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states. Arthritis Rheum 1997; 40: 672-82.
17. VAN VENROOIJ WJ, CHARLES P, MAINI RN: The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991; 140: 181-9.
18. BERNSTEIN R: Autoantibodies to histones, Sm and ubiquitins. In VAN VENROOIJ WJ and MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers 1996; C2: 2:1-7.
19. DE KEYSER F, VERBRUGGEN G, VEYS EM et al.: Identification of a new antinuclear antibody by immunoblotting. Clin Chem 1990; 36: 337-9.
20. NAKAMURA RM, TAN EM: Update on autoantibodies to intracellular antigens in systemic rheumatic diseases. Clin Lab Med 1992; 12:1-23.
21. PENG SL, CRAFT JE: Spliceosomal snRNPs autoantibodies. In PETER JB and SHOENFELD Y (Eds.): Autoantibodies. Amsterdam, Elsevier Sciences 1996:774-82.
22. HACKL W, FISCHER U, LÜHRMANN R: A 69-kD protein that associates reversibly with the Sm core domain of several spliceosomal snRNP species. J Cell Biol 1994; 124: 261-72.
23. WILLIAMS DG, STOCKS MR, CHARLES PJ, MAINI RN: Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: A comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods 1986; 91:65-73.
24. KELEKAR A, SAITTA MR, KEENE JD: Molecular composition of Ro small ribonucleoprotein complexes in human cells, Intracellular localization of the 60-and 52-kD proteins. J Clin Invest 1994; 92: 1637-44.
25. BOIRE G, GENDRON M, MONAST N, BASTIN B, MÉNARD HA: Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995; 100: 489-98.
26. BOULANGER C, CHABOT B, MÉNARD HA, BOIRE G: Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol 1995; 99: 29-36.
27. YELL JA, WANG L, YIN H, MCCAULIFFE DP: Disparate locations of the 52-and 60-kDa Ro/ SS-A antigens in cultured human keratinocytes. J Invest Dermatol 1996; 107: 622-6.
28. MCCAULIFFE DP, YIN H, WANG LX, LUCAS L: Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. J Rheumatol 1994; 21: 1073-80.
29. BÖZIC B, PRUIJN GJM, ROZMAN B, VAN VENROOIJ WJ: Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein. Clin Exp Immunol 1993; 94: 227-35.
30. ZIMMERMANN C, SMOLEN JS, GRANINGER W et al.: Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus. J Rheumatol 1996; 23: 1897-1903.
31. ROUTSIAS JG, TZIOUFAS AG, SAKARELLOS-DAITSIOTIS M, SAKARELLOS C, MOUT-SOPOULOS HM: Epitope mapping of the Ro/ SSA 6OkD autoantigen reveals disease-specific antibody-binding profiles. J Clin Invest 1996; 26: 514-21.
32. CHAN EKL, BUYON JP: The SS-A/Ro antigen. In VAN VENROOIJ WJ and MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers 1996: B4: 1-18.
33. BOIRE G, LOPEZ-LONGO F-J, LAPOINTE S, MENARD H-A: Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. Arthritis Rheum 1991; 34: 722-30.
34. ITOH Y, REICHLIN M: Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992; 14: 57-65.
35. HUANG S-C, SCOFIELD RH, KURIEN BT, HARLEY JB: Human anti-Ro autoantibodies bind multiple conformational epitopes of 60-kD Ro autoantigen. J Clin Immunol 1997; 17: 212-9.
36. REICHLIN M, RADER M, HARLEY JB: Autoimmune response to the Ro/SSA particle is directed to the human antigen. Clin Exp Immunol 1989; 76: 373-7.
37. MCCAULIFFE DP, WANG L, SATOH M, REEVES WH, SMALL D: Recombinant 52 kDA Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol 1997; 24: 860-6.
38. ++ binding domain of the human Ro 52 kDa protein is a target for conformation-dependent autoantibodies. J Autoimmun 1998; 11: 11-7.
39. TSUZAKA K, FUJII T, AKIZUKI M et al.: Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-a proteins in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol 1997; 24: 860-6.
40. BUYON JP, SLADE SG, REVEILLE JD, HAMEL JC, CHAN EKL: Autoantibody responses to the native 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjögren's syndrome. J Immunol 1994; 152: 3675-84.
41. RUTJES SA, EGBERTS WTMV, JONGEN P, VAN DEN HOOGEN F, PRUIJN GJM, VAN VENROOIJ WJ: Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32-40.
42. ROTHFIELD NF: Autoantibodies to scleroderma-associated antigens. In VAN VENROOIJ WJ and MAINI RN (Eds.): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers 1996: C5.1:1-7.
43. KAMEDA H, KUWANA M, HAMA N, KABURAKI J, HOMMA M: Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases. J Rheumatol 1997; 24:400-3.
44. BARON M, SROLOVITZ H, LANDER P, KAPUSTA M: The coexistence of rheumatoid arthritis and scleroderma: A case report and review of the literature. J Rheumatol 1982; 9: 947-9.
45. COHEN MJ, PERSELLIN RH: Coexistence of rheumatoid arthritis and systemic sclerosis in four patients. Scand J Rheumatol 1982; 11: 241-5.
46. GENDI N, GORDONT, TANNER SDB, BLACK CM: The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 1992; 31: 783-6.
47. ROZENBAUM M, ROSNER I: The coexistence of intractable nodular rheumatoid arthritis and scleroderma. Br J Rheumatol 1993; 32: 82-3.
48. HORIKI T, MORIUCHI J, TAKAYA M et al.: The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum 1996; 39: 152-6.